We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
-15.5%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$580M
AUM Growth
+$65.1M
Cap. Flow
+$160M
Cap. Flow %
27.62%
Top 10 Hldgs %
14.16%
Holding
381
New
49
Increased
90
Reduced
39
Closed
56

Top Sells

Rank Stock Value
1
HRB icon
H&R Block
HRB
+$3.86M
2
GLD icon
SPDR Gold Trust
GLD
+$3.79M
3
IAU icon
iShares Gold Trust
IAU
+$3.59M
4
RRC icon
Range Resources
RRC
+$2.82M
5
CMBM
Cambium Networks
CMBM
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 18.08%
2 Healthcare 15.35%
3 Consumer Discretionary 15.1%
4 Materials 10.18%
5 Consumer Staples 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
101
Universal Health Services
UHS
$10.4B
$2.1M 0.36%
20,800
+17,700
+571% +$2.22M
CPE
102
DELISTED
Callon Petroleum Company
CPE
$2M 0.34%
51,000
ACLS icon
103
Axcelis
ACLS
$4.17B
$2M 0.34%
+36,400
New +$2.11M
QLYS icon
104
Qualys
QLYS
$6.59B
$1.96M 0.34%
+15,500
New +$2.03M
FXE icon
105
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$1.94M 0.33%
20,000
MMS icon
106
Maximus
MMS
$3.32B
$1.94M 0.33%
31,000
+15,400
+99% +$1.04M
GEF icon
107
Greif
GEF
$5.12B
$1.93M 0.33%
31,000
-21,000
-40% -$1.28M
GILD icon
108
Gilead Sciences
GILD
$162B
$1.93M 0.33%
31,200
WBD icon
109
Warner Bros
WBD
$64.6B
$1.91M 0.33%
142,578
+12,578
+10% +$233K
MATX icon
110
Matsons
MATX
$6.32B
$1.9M 0.33%
+26,000
New +$2.24M
VIVO
111
DELISTED
Meridian Bioscience Inc
VIVO
$1.89M 0.33%
+62,000
New +$1.68M
USNA icon
112
Usana Health Sciences
USNA
$276M
$1.88M 0.32%
26,000
HZO icon
113
MarineMax
HZO
$808M
$1.88M 0.32%
52,000
SBH icon
114
Sally Beauty Holdings
SBH
$1.56B
$1.86M 0.32%
156,000
RHI icon
115
Robert Half
RHI
$4.13B
$1.86M 0.32%
+24,800
New +$2.35M
CRI icon
116
Carter's
CRI
$1.44B
$1.83M 0.32%
26,000
ORCL icon
117
Oracle
ORCL
$417B
$1.82M 0.31%
26,000
PLAB icon
118
Photronics
PLAB
$1.89B
$1.81M 0.31%
+93,000
New +$1.63M
WPM icon
119
Wheaton Precious Metals
WPM
$55.8B
$1.8M 0.31%
50,000
-30,000
-38% -$1.3M
IRWD icon
120
Ironwood Pharmaceuticals
IRWD
$718M
$1.8M 0.31%
156,000
+104,000
+200% +$1.23M
KHC icon
121
Kraft Heinz
KHC
$30.3B
$1.77M 0.31%
46,500
-31,500
-40% -$1.26M
CNXC icon
122
Concentrix
CNXC
$1.57B
$1.76M 0.3%
13,000
+7,800
+150% +$1.17M
GHC icon
123
Graham Holdings Company
GHC
$5.12B
$1.76M 0.3%
3,100
-2,100
-40% -$1.25M
FXY icon
124
Invesco CurrencyShares Japanese Yen Trust
FXY
$451M
$1.72M 0.3%
25,000
+24,000
+2,400% +$1.73M
WAT icon
125
Waters Corp
WAT
$39.3B
$1.72M 0.3%
5,200

Similar funds

Hussman Strategic Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Hussman Strategic Advisors held 381 positions worth $580M, up 13% from $515M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors deployed $160M of net new capital in Q2 2022, opening 49 new positions and adding to 90 existing holdings. Its largest new stake was Cirrus Logic: 62,000 shares worth $4.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was H&R Block, an estimated $3.86M trimmed.

  • Hussman Strategic Advisors's largest Q2 2022 buy was Cirrus Logic: 62,000 shares worth $4.5M.
  • Hussman Strategic Advisors added most to Amazon in Q2 2022, an estimated $7.76M increase.
  • Hussman Strategic Advisors's biggest Q2 2022 reduction was H&R Block, cutting an estimated $3.86M.
  • Hussman Strategic Advisors fully exited Cambium Networks in Q2 2022, selling an estimated $2.58M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $580M portfolio in Q2 2022.
  • Hussman Strategic Advisors opened 49 new positions and closed 56 in Q2 2022.
  • Hussman Strategic Advisors's portfolio value rose 13% quarter-over-quarter to $580M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2022, filed 12 Sep 2022.